| 2024-04 |
Clinical, qualitative imaging biomarkers, and tumor oxygenation imaging biomarkers for differentiation of midline-located IDH wild-type glioblastomas and H3 K27-altered diffuse midline gliomas in adults |
European Journal of Radiology
|
| 2024-02 |
The importance of considering competing risks in recurrence analysis of intracranial meningioma |
Journal of Neuro-Oncology
|
| 2024-02 |
Rethinking extent of resection of contrast-enhancing and non-enhaning tumor: different survival impacts on adult-type diffuse gliomas in 2021 World Health Organization classification |
European Radiology
|
| 2024-02 |
11C-Acetate PET/CT for Reactive Astrogliosis Outperforms 11C-Methionine PET/CT in Glioma Classification and Survival Prediction |
Clinical Nuclear Medicine
|
| 2024-01 |
High Radiation Dose to the Fornix Causes Symptomatic Radiation Necrosis in Patients with Anaplastic Oligodendroglioma |
Yonsei Medical Journal
|
| 2023-12 |
The 2021 WHO Classification for Gliomas and Implications on Imaging Diagnosis: Part 3—Summary of Imaging Findings on Glioneuronal and Neuronal Tumors |
Journal of Magnetic Resonance Imaging
|
| 2023-11 |
Impact of boost sequence in concurrent chemo-radiotherapy on newly diagnosed IDH-wildtype glioblastoma multiforme |
Journal of Neuro-Oncology
|
| 2023-11 |
The Mediating Effect of Uncertainty in Illness on Cancer Coping in Patients With Primary Malignant Brain Tumors |
Cancer Nursing
|
| 2023-10 |
Classification of IDH wild-type glioblastoma tumorspheres into low- and high-invasion groups based on their transcriptional program |
British Journal of Cancer
|
| 2023-09 |
Association of partial T2-FLAIR mismatch sign and isocitrate dehydrogenase mutation in WHO grade 4 gliomas: results from the ReSPOND consortium |
Neuroradiology
|
| 2023-09 |
The 2021 WHO Classification for Gliomas and Implications on Imaging Diagnosis: Part 2-Summary of Imaging Findings on Pediatric-Type Diffuse High-Grade Gliomas, Pediatric-Type Diffuse Low-Grade Gliomas, and Circumscribed Astrocytic Gliomas |
Journal of Magnetic Resonance Imaging
|
| 2023-09 |
The 2021 WHO Classification for Gliomas and Implications on Imaging Diagnosis: Part 1-Key Points of the Fifth Edition and Summary of Imaging Findings on Adult-Type Diffuse Gliomas |
Journal of Magnetic Resonance Imaging
|
| 2023-09 |
Dynamic contrast-enhanced MRI radiomics model predicts epidermal growth factor receptor amplification in glioblastoma, IDH-wildtype |
Journal of Neuro-Oncology
|
| 2023-09 |
Novel Postoperative Serum Biomarkers in Atypical Meningiomas: A Multicenter Study |
Neurosurgery
|
| 2023-08 |
Erdafitinib in patients with advanced solid tumours with FGFR alterations (RAGNAR): an international, single-arm, phase 2 study |
The Lancet Oncology
|
| 2023-07 |
Astrocytic scar restricting glioblastoma via glutamate–MAO-B activity in glioblastoma-microglia assembloid |
Biomaterials Research
|
| 2023-07 |
what we need to know about uncertainty in illness among people with primary malignant brain tumours: A mixed‐methods systematic review |
Journal of Clinical Nursing
|
| 2023-07 |
C5α secreted by tumor mesenchymal stem-like cells mediates resistance to 5-aminolevulinic acid-based photodynamic therapy against glioblastoma tumorspheres |
Journal of Cancer Research and Clinical Oncology
|
| 2023-06 |
Efficacy and safety of metformin plus low-dose temozolomide in patients with recurrent or refractory glioblastoma: a randomized, prospective, multicenter, double-blind, controlled, phase 2 trial (KNOG-1501 study) |
Discover Oncology
|
| 2023-05 |
Korean Brain Tumor Society Consensus Review for the Practical Recommendations on Glioma Management in Korea |
Journal of Korean Neurosurgical Society
|
| 2023-05 |
Comparison of Single-Session, Neoadjuvant, and Adjuvant Embolization Gamma Knife Radiosurgery for Arteriovenous Malformation |
Neurosurgery
|
| 2023-03 |
Revisiting prognostic factors in glioma with leptomeningeal metastases: a comprehensive analysis of clinical and molecular factors and treatment modalities |
Journal of Neuro-Oncology
|
| 2023-03 |
Mesenchymal Stem-Like Cells Derived from the Ventricle More Effectively Enhance Invasiveness of Glioblastoma Than Those Derived from the Tumor |
Yonsei Medical Journal
|
| 2023-02 |
Qualitative and Quantitative Magnetic Resonance Imaging Phenotypes May Predict CDKN2A/B Homozygous Deletion Status in Isocitrate Dehydrogenase-Mutant Astrocytomas: A Multicenter Study |
Korean Journal of Radiology
|
| 2022-12 |
Adding radiomics to the 2021 WHO updates may improve prognostic prediction for current IDH-wildtype histological lower-grade gliomas with known EGFR amplification and TERT promoter mutation status |
EUROPEAN RADIOLOGY
|
| 2022-12 |
Federated learning enables big data for rare cancer boundary detection |
Nature Communications
|
| 2022-11 |
Leptomenngeal metastases in glioma revisited: incidence and molecular predictors based on postcontrast fluid-attenuated inversion recovery imaging |
Journal of Neurosurgery
|
| 2022-11 |
Assessing Spatial Distribution of Multicellular Self-Assembly Enables the Prediction of Phenotypic Heterogeneity in Glioblastoma |
Cancers
|
| 2022-11 |
Dual inhibition of CPT1A and G6PD suppresses glioblastoma tumorspheres |
JOURNAL OF NEURO-ONCOLOGY
|
| 2022-11 |
Two independent variants of epidermal growth factor receptor associated with risk of glioma in a Korean population |
SCIENTIFIC REPORTS
|
| 2022-11 |
Asian-specific 3'UTR variant in CDKN2B associated with risk of pituitary adenoma |
Molecular Biology Reports
|
| 2022-11 |
Tissue Niche Miniature of Glioblastoma Patient Treated with Nano-Awakeners to Induce Suicide of Cancer Stem Cells |
Advanced Healthcare Materials
|
| 2022-10 |
Three-dimensional fractal dimension and lacunarity features may noninvasively predict TERT Promoter mutation stuatus in grade 2 meningiomas |
PLoS ONE
|
| 2022-10 |
Etomoxir, a carnitine palmitoyltransferase 1 inhibitor, combined with temozolomide reduces stemness and invasiveness in patient-derived glioblastoma tumorspheres |
Cancer Cell International
|
| 2022-10 |
11 C-Acetate PET/CT Detects Reactive Astrogliosis Helping Glioma Classification |
Clinical Nuclear Medicine
|
| 2022-09 |
Sex as a prognostic factor in adult-type diffuse gliomas: an integrated clinical and molecular analysis according to the 2021 WHO classification |
JOURNAL OF NEURO-ONCOLOGY
|
| 2022-08 |
Clinical factors and conventional MRI may independently predict progression-free survival and overall survival in adult pilocytic astrocytomas |
Neuroradiology
|
| 2022-08 |
A fully automatic multiparametric radiomics model for differentiation of adult pilocytic astrocytomas from high-grade gliomas |
European Radiology
|
| 2022-08 |
Pseudoprogression and peritumoral edema due to intratumoral necrosis after Gamma knife radiosurgery for meningioma |
Scientific Reports
|
| 2022-08 |
An interpretable radiomics model to select patients for radiotherapy after surgery for WHO grade 2 meningiomas |
Radiation Oncology
|
| 2022-08 |
Patterns of recurrence according to the extent of resection in patients with IDH-wild-type glioblastoma: a retrospective study |
Journal of Neurosurgery
|
| 2022-08 |
A lignan from Alnus japonica inhibits glioblastoma tumorspheres by suppression of FOXM1 |
SCIENTIFIC REPORTS
|
| 2022-07 |
Recent Update on Neurosurgical Management of Brain Metastasis |
Brain Tumor Research and Treatment
|
| 2022-07 |
Adjuvant Radiotherapy Versus Surveillance for Grade 2 Intracranial Meningiomas: A Multi-Institutional Propensity Score-Matched Study |
FRONTIERS IN ONCOLOGY
|
| 2022-05 |
Early-onset adverse events after stereotactic radiosurgery for jugular foramen schwannoma: a mid-term follow-up single-center review of 46 cases |
RADIATION ONCOLOGY
|
| 2022-04 |
Influence of Concurrent and Adjuvant Temozolomide on Health-Related Quality of Life of Patients with Grade III Gliomas: A Secondary Analysis of a Randomized Clinical Trial (KNOG-1101 Study) |
CANCER RESEARCH AND TREATMENT
|
| 2022-01 |
Clinical and diffusion parameters may noninvasively predict TERT promoter mutation status in grade II meningiomas |
JOURNAL OF NEURORADIOLOGY
|
| 2022-01 |
The role of postoperative radiotherapy in intracranial solitary fibrous tumor/hemangiopericytoma: a multi-institutional retrospective study (KROG 18-11) |
CANCER RESEARCH AND TREATMENT
|
| 2022-01 |
Clinicopathological differences in radiation-induced organizing hematomas of the brain based on type of radiation treatment and primary lesions |
Journal of Pathology and Translational Medicine
|
| 2022-01 |
Levetiracetam as a sensitizer of concurrent chemoradiotherapy in newly diagnosed glioblastoma: an open-label phase 2 study |
CANCER MEDICINE
|
| 2022-01 |
Quality of Radiomics Research on Brain Metastasis: A Roadmap to Promote Clinical Translation |
Korean Journal of Radiology
|
| 2022-01 |
Association of MGMT Gene Promoter Methylation with Clinicopathological Parameters in Patients with Wild-type IDH Glioblastoma |
ANTICANCER RESEARCH
|
| 2022-01 |
A novel biguanide (IM1761065) inhibits bioenergetics of glioblastoma tumorspheres |
JOURNAL OF NEURO-ONCOLOGY
|
| 2021-12 |
Radiomics and Deep Learning in Brain Metastases: Current Trends and Roadmap to Future Applications |
Investigative Magnetic Resonance Imaging
|
| 2021-12 |
Radiomics-based prediction of multiple gene alteration incorporating mutual genetic information in glioblastoma and grade 4 astrocytoma, IDH-mutant |
JOURNAL OF NEURO-ONCOLOGY
|
| 2021-11 |
Soluble ICAM-1 a Pivotal Communicator between Tumors and Macrophages, Promotes Mesenchymal Shift of Glioblastoma |
Advanced Science
|
| 2021-11 |
Stereotactic biopsy for adult brainstem lesions: A surgical approach and its diagnostic value according to the 2016 World Health Organization Classification |
CANCER MEDICINE
|
| 2021-11 |
Dynamic contrast-enhanced MRI may be helpful to predict response and prognosis after bevacizumab treatment in patients with recurrent high-grade glioma: comparison with diffusion tensor and dynamic susceptibility contrast imaging |
NEURORADIOLOGY
|
| 2021-10 |
Intracranial Extraskeletal Myxoid Chondrosarcoma in Fourth Ventricle |
Brain Tumor Reserach and Treatment
|
| 2021-10 |
Anterior skull base reconstruction using an anterolateral thigh free flap |
Archives of Craniofacial Surgery
|
| 2021-10 |
Endoscopic transorbital approach to the insular region: Cadaveric feasibility study and clinical application (SevEN-005) |
JOURNAL OF NEUROSURGERY
|
| 2021-10 |
A diagnostic tree for differentiation of adult pilocytic astrocytomas from high-grade gliomas |
EUROPEAN JOURNAL OF RADIOLOGY
|
| 2021-10 |
Influence of the amount of fresh specimen on the isolation of tumor mesenchymal stem-like cells from high-grade glioma |
YONSEI MEDICAL JOURNAL
|
| 2021-09 |
Efficacy of Whole-Ventricular Radiotherapy in Patients Undergoing Maximal Tumor Resection for Glioblastomas Involving the Ventricle |
FRONTIERS IN ONCOLOGY
|
| 2021-08 |
Magnetic Resonance Imaging Parameters for Noninvasive Prediction of Epidermal Growth Factor Receptor Amplification in Isocitrate Dehydrogenase-Wild-Type Lower-Grade Gliomas: A Multicenter Study |
NEUROSURGERY
|
| 2021-08 |
Identification of magnetic resonance imaging features for the prediction of molecular profiles of newly diagnosed glioblastoma |
JOURNAL OF NEURO-ONCOLOGY
|
| 2021-05 |
Predictive Factors of Radiation-Induced Changes Following Single-Session Gamma Knife Radiosurgery for Arteriovenous Malformations |
Journal of Clinical Medicine
|
| 2021-05 |
Quality assessment of meningioma radiomics studies: bridging the gap between exploratory research and clinlical applications |
EUROPEAN JOURNAL OF RADIOLOGY
|
| 2021-04 |
The Korean Society for Neuro-Oncology (KSNO) guideline for antiepileptic drug usage of brain tumor: Version 2021.1 |
Brain Tumor Reserach and Treatment
|
| 2021-04 |
The Korean Society for Neuro-Oncology (KSNO) Guideline for Adult Diffuse Midline Glioma: Version 2021.1 |
Brain Tumor Reserach and Treatment
|
| 2021-03 |
MRI features may predict molecular features of glioblastoma in isocitrate dehydrogenase wild-type lower-grade gliomas |
AMERICAN JOURNAL OF NEURORADIOLOGY
|
| 2021-03 |
Triggered electrooculography for identification of oculomotor and abducens nerves during skull base surgery |
JOURNAL OF KOREAN NEUROSURGICAL SOCIETY
|
| 2021-03 |
Diffusion tensor and postcontrast T1-weighted imaging radiomics to differentiate the epidermal growth factor receptor mutation status of brain metastases from non-small cell lung cancer |
NEURORADIOLOGY
|
| 2021-03 |
Differentiation of recurrent diffuse glioma from treatment-induced change using amide proton transfer imaging: incremental value to diffusion and perfusion parameters |
NEURORADIOLOGY
|
| 2021-02 |
Fully automated hybrid approach to predict the IDH mutation status of gliomas via deep learning and radiomics |
NEURO-ONCOLOGY
|
| 2021-02 |
Differentiation of recurrent glioblastoma from radiation necrosis using diffusion radiomics with machine learning model development and external validation |
SCIENTIFIC REPORTS
|
| 2021-02 |
The behavior of residual tumors following incomplete surgical resection for vestibular schwannomas |
SCIENTIFIC REPORTS
|
| 2021-01 |
Combinatorial Therapeutic Effect of Inhibitors of Aldehyde Dehydrogenase and Mitochondrial Complex I, and the Chemotherapeutic Drug, Temozolomide against Glioblastoma Tumorspheres |
MOLECULES
|
| 2020-12 |
Co-expression of cancer driver genes: IDH-wildtype glioblastoma-derived tumorspheres |
JOURNAL OF TRANSLATIONAL MEDICINE
|
| 2020-12 |
Choroid plexus as the best reference region for standardized uptake value analysis on C11-acetate PET/CT for grading and predicting prognosis in patients with cerebral gliomas |
Nuclear Medicine and Molecular Imaging
|
| 2020-12 |
Diffusion and perfusion MRI may predict EGFR amplification and the TERT promoter mutation status of IDH-wildtype lower-grade gliomas |
EUROPEAN RADIOLOGY
|
| 2020-12 |
Radiomics risk score may be a potential imaging biomarker for predicting survival in isocitrate dehydrogenase wild-type lower-grade gliomas |
EUROPEAN RADIOLOGY
|
| 2020-12 |
Ambient carbon monoxide exposure and elevated risk of mortality in the glioblastoma patients: A double-cohort retrospective observational study |
CANCER MEDICINE
|
| 2020-12 |
Radiosurgery vs. microsurgery for newly diagnosed, small petroclival meningiomas with trigeminal neuralgia |
NEUROSURGICAL REVIEW
|
| 2020-11 |
Temporal volume change of cavernous sinus cavernous hemangiomas after Gamma Knife surgery |
YONSEI MEDICAL JOURNAL
|
| 2020-11 |
Combined effects of niclosamide and temozolomide against human glioblastoma tumorspheres |
JOURNAL OF CANCER RESEARCH AND CLINICAL ONCOLOGY
|
| 2020-10 |
Crosstalk between GBM cells and mesenchymal stemlike cells promotes the invasiveness of GBM through the C5a/p38/ZEB1 axis |
NEURO-ONCOLOGY
|
| 2020-10 |
Survival, prognostic factors, and volumetric analysis of extent of resection for anaplastic gliomas |
CANCER RESEARCH AND TREATMENT
|
| 2020-10 |
Glioblastomas harboring gene fusions detected by next-generation sequencing |
BRAIN TUMOR PATHOLOGY
|
| 2020-09 |
Podoplanin-Targetable MR/OPTIC Dual-Mode Nanocomposites for Glioblastoma Multiforme in Mouse Brain Cancer |
DIGEST JOURNAL OF NANOMATERIALS AND BIOSTRUCTURES
|
| 2020-09 |
Postoperative Radiotherapy for WHO Grade II-III Intracranial Ependymoma in Adults: An Intergroup Collaborative Study (KROG 18-06/KNOG 18-01) |
RADIOTHERAPY AND ONCOLOGY
|
| 2020-08 |
Magnetic resonance imaging-based 3-dimensional fractal dimension and lacunarity analyses may predict the meningioma grade |
EUROPEAN RADIOLOGY
|
| 2020-07 |
ATM mutations improve radio-sensitivity in wild-type isocitrate dehydrogenase-associated high grade glioma: retrospective analysis using next-generaion sequencing data |
RADIATION ONCOLOGY
|
| 2020-07 |
Glucose loading enhances the value of 18F-FDG PET/CT for the characterization and delineation of cerebral gliomas |
Cancers
|
| 2020-07 |
Integrated pharmaco-proteogenomics defines two subgroups in isocitrate dehydrogenase wild-type glioblastoma with prognostic and therapeutic opportunities |
NATURE COMMUNICATIONS
|
| 2020-07 |
Association of survival and levetiracetam use in patients with glioblastoma treated with temozolomide chemoradiotherapy |
SCIENTIFIC REPORTS
|
| 2020-07 |
A rare case of oligodendroglioma with gangliocytic differentiation in a 31‑year‑old male: importance of genetic testing for IDH1/2 |
BRAIN TUMOR PATHOLOGY
|